Skip to main content

REVIEW article

Front. Cell Dev. Biol.
Sec. Cancer Cell Biology
Volume 13 - 2025 | doi: 10.3389/fcell.2025.1551003
This article is part of the Research Topic Clinical Advances and Practice of Digestive System Cancer Progression and Metastasis Induced by Immune Factors View all articles

Ferritinophagy: Multifaceted Roles and Potential Therapeutic Strategies in Liver Diseases

Provisionally accepted
Lin Zhuang Lin Zhuang 1*Kejia Wu Kejia Wu 2Wei Zhao Wei Zhao 3Zeyu Hou Zeyu Hou 2Weigang Zhang Weigang Zhang 2Xiaofeng Xue Xiaofeng Xue 2Junyi Qiu Junyi Qiu 2Daobin Wang Daobin Wang 2Lei Qin Lei Qin 2Ding Sun Ding Sun 2
  • 1 Changzhou Wujin People's Hospital, Changning, China
  • 2 The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China
  • 3 Xinyi People's Hospital, Xuzhou, Jiangsu Province, China

The final, formatted version of the article will be published soon.

    Ferritinophagy, the selective autophagic degradation of ferritin to release iron, is emerging as a critical regulator of iron homeostasis and a key player in the pathogenesis of various liver diseases. This review comprehensively examines the mechanisms, regulation, and multifaceted roles of ferritinophagy in liver health and disease. Ferritinophagy is intricately regulated by several factors, including Nuclear Receptor Coactivator 4 (NCOA4), Iron regulatory proteins (IRPs), and signaling pathways such as mTOR and AMPK. These regulatory mechanisms ensure proper iron utilization and prevent iron overload, which can induce oxidative stress and ferroptosis.In liver diseases, ferritinophagy exhibits dual roles. In liver fibrosis, promoting ferritinophagy in hepatic stellate cells (HSCs) can induce cell senescence and reduce fibrosis progression. However, in non-alcoholic fatty liver disease (NAFLD), chronic ferritinophagy may exacerbate liver injury through iron overload and oxidative stress.In hepatocellular carcinoma (HCC), ferritinophagy can be harnessed as a novel therapeutic strategy by inducing ferroptosis in cancer cells. Additionally, ferritinophagy is implicated in drug-induced liver injury and sepsis-associated liver damage, highlighting its broad impact on liver pathology. This review also explores the crosstalk between ferritinophagy and other selective autophagy pathways, such as mitophagy and lipophagy, which collectively influence cellular homeostasis and disease progression. Understanding these interactions is essential for developing comprehensive therapeutic strategies targeting multiple autophagy pathways.In summary, ferritinophagy is a complex and dynamic process with significant implications for liver diseases. This review provides an in-depth analysis of ferritinophagy's regulatory mechanisms and its potential as a therapeutic target, emphasizing the need for further research to elucidate its role in liver health and disease.

    Keywords: :Ferritinophagy, Autophagy, ferroptosis, NAFLD, HCC, liver fibrosis

    Received: 24 Dec 2024; Accepted: 06 Feb 2025.

    Copyright: © 2025 Zhuang, Wu, Zhao, Hou, Zhang, Xue, Qiu, Wang, Qin and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Lin Zhuang, Changzhou Wujin People's Hospital, Changning, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.